We are live on ! Find out more
JHP

James Hambro & Partners Portfolio holdings

AUM $2.76B
1-Year Est. Return 19.67%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
+19.67%
3 Year Est. Return
+79.16%
5 Year Est. Return
+89.36%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$131M
Cap. Flow
-$86.1M
Cap. Flow %
-3.41%
Top 10 Hldgs %
63.35%
Holding
54
New
–
Increased
17
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.58M
2
AMZN icon
Amazon
AMZN
+$6.61M
3
TXN icon
Texas Instruments
TXN
+$5.18M
4
ENTG icon
Entegris
ENTG
+$5.05M
5
ISRG icon
Intuitive Surgical
ISRG
+$5.01M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$129M
2
APH icon
Amphenol
APH
+$3.8M
3
PGR icon
Progressive
PGR
+$3M
4
IRM icon
Iron Mountain
IRM
+$2.27M
5
V icon
Visa
V
+$1.37M

Sector Composition

Rank Sector Weight
1 Financials 30.93%
2 Technology 27.89%
3 Healthcare 11.5%
4 Consumer Discretionary 9.63%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CP icon
26
Canadian Pacific Kansas City
CP
$78.1B
$1.51M 0.06%
19,000
-315
-2% -$24.2K
FERG icon
27
Ferguson
FERG
$45.4B
$1.35M 0.05%
6,176
-135
-2% -$24.9K
PLD icon
28
Prologis
PLD
$135B
$1.31M 0.05%
12,427
+2,532
+26% +$266K
IXN icon
29
iShares Global Tech ETF
IXN
$8.32B
$1.2M 0.05%
13,050
– –
VHT icon
30
Vanguard Health Care ETF
VHT
$18.1B
$972K 0.04%
3,915
-550
-12% -$136K
WMT icon
31
Walmart Inc
WMT
$885B
$916K 0.04%
9,372
– –
NVDA icon
32
NVIDIA
NVDA
$4.86T
$864K 0.03%
5,470
-170
-3% -$21.4K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$756K 0.03%
1,559
-80
-5% -$40.6K
CVX icon
34
Chevron
CVX
$392B
$687K 0.03%
4,800
– –
IRM icon
35
Iron Mountain
IRM
$36.4B
$667K 0.03%
6,502
-24,110
-79% -$2.27M
NOC icon
36
Northrop Grumman
NOC
$77.1B
$559K 0.02%
1,117
+100
+10% +$49.2K
AAPL icon
37
Apple
AAPL
$4.54T
$540K 0.02%
2,633
-2,071
-44% -$418K
SYY icon
38
Sysco
SYY
$40.8B
$530K 0.02%
7,000
– –
MRSH
39
Marsh
MRSH
$90.5B
$509K 0.02%
2,326
-485
-17% -$109K
INTU icon
40
Intuit
INTU
$86.5B
$480K 0.02%
610
-660
-52% -$447K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$456K 0.02%
738
– –
JNJ icon
42
Johnson & Johnson
JNJ
$618B
$375K 0.01%
2,458
-380
-13% -$58.4K
XEL icon
43
Xcel Energy
XEL
$48.8B
$368K 0.01%
5,400
– –
ABBV icon
44
AbbVie
ABBV
$443B
$325K 0.01%
1,750
– –
WFC icon
45
Wells Fargo
WFC
$261B
$322K 0.01%
4,019
– –
PODD icon
46
Insulet
PODD
$11.5B
$287K 0.01%
915
– –
ABT icon
47
Abbott
ABT
$183B
$279K 0.01%
2,050
– –
HD icon
48
Home Depot
HD
$331B
$275K 0.01%
750
-150
-17% -$54.3K
LLY icon
49
Eli Lilly
LLY
$1.02T
$256K 0.01%
328
-12
-4% -$9.32K
BAC icon
50
Bank of America
BAC
$435B
$253K 0.01%
5,357
– –
1
2
3

Similar funds

NSLI
Nan Shan Life Insurance Taipei City, Taiwan $2.76B AUM 6.75% 1-Year Est. Return
JFGIW
Johnson Financial Group Inc (Wisconsin) Racine, Wisconsin $2.76B AUM 19.4% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
MC
Maplelane Capital New York $2.79B AUM 52.02% 1-Year Est. Return

James Hambro & Partners's Q2 2025 Portfolio in Review

As of Q2 2025, James Hambro & Partners held 54 positions worth $2.53B, up 5.5% from $2.4B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

James Hambro & Partners withdrew a net $86.1M in Q2 2025, closing 4 positions and reducing 22 holdings. Its most notable exit was UnitedHealth, an estimated $129M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, James Hambro & Partners added an estimated $9.58M to Thermo Fisher Scientific.

  • James Hambro & Partners added most to Thermo Fisher Scientific in Q2 2025, an estimated $9.58M increase.
  • James Hambro & Partners's biggest Q2 2025 reduction was Amphenol, cutting an estimated $3.8M.
  • James Hambro & Partners fully exited UnitedHealth in Q2 2025, selling an estimated $129M.
  • James Hambro & Partners's ten largest holdings make up 63% of its $2.53B portfolio in Q2 2025.
  • James Hambro & Partners opened 0 new positions and closed 4 in Q2 2025.
  • James Hambro & Partners's portfolio value rose 5.5% quarter-over-quarter to $2.53B.

Based on James Hambro & Partners's 13F filing for Q2 2025, filed 17 Jul 2025.